BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14504467)

  • 1. SUMO and transcriptional repression: dynamic interactions between the MAP kinase and SUMO pathways.
    Yang SH; Jaffray E; Senthinathan B; Hay RT; Sharrocks AD
    Cell Cycle; 2003; 2(6):528-30. PubMed ID: 14504467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.
    Yang SH; Jaffray E; Hay RT; Sharrocks AD
    Mol Cell; 2003 Jul; 12(1):63-74. PubMed ID: 12887893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO promotes HDAC-mediated transcriptional repression.
    Yang SH; Sharrocks AD
    Mol Cell; 2004 Feb; 13(4):611-7. PubMed ID: 14992729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIASx acts as an Elk-1 coactivator by facilitating derepression.
    Yang SH; Sharrocks AD
    EMBO J; 2005 Jun; 24(12):2161-71. PubMed ID: 15920481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1.
    Yang SH; Sharrocks AD
    Biochem Soc Symp; 2006; (73):121-9. PubMed ID: 16626293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ETS domain transcription factor Elk-1 contains a novel class of repression domain.
    Yang SH; Bumpass DC; Perkins ND; Sharrocks AD
    Mol Cell Biol; 2002 Jul; 22(14):5036-46. PubMed ID: 12077333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1.
    Yang SH; Shore P; Willingham N; Lakey JH; Sharrocks AD
    EMBO J; 1999 Oct; 18(20):5666-74. PubMed ID: 10523309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of ternary complex factor Elk-1 by stress-activated protein kinases.
    Gille H; Strahl T; Shaw PE
    Curr Biol; 1995 Oct; 5(10):1191-200. PubMed ID: 8548291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo.
    Davis S; Vanhoutte P; Pages C; Caboche J; Laroche S
    J Neurosci; 2000 Jun; 20(12):4563-72. PubMed ID: 10844026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.
    Enslen H; Tokumitsu H; Stork PJ; Davis RJ; Soderling TR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10803-8. PubMed ID: 8855261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.
    Yang SH; Whitmarsh AJ; Davis RJ; Sharrocks AD
    EMBO J; 1998 Mar; 17(6):1740-9. PubMed ID: 9501095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T; Stewart S; Han M; Guan KL
    EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast.
    Tresini M; Lorenzini A; Frisoni L; Allen RG; Cristofalo VJ
    Exp Cell Res; 2001 Oct; 269(2):287-300. PubMed ID: 11570821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase.
    Rao VN; Reddy ES
    Cancer Res; 1993 Aug; 53(15):3449-54. PubMed ID: 8339245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.
    Yang SH; Sharrocks AD
    Mol Cell; 2006 May; 22(4):477-87. PubMed ID: 16713578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of MAP kinase signal transduction pathways at the serum response element.
    Whitmarsh AJ; Shore P; Sharrocks AD; Davis RJ
    Science; 1995 Jul; 269(5222):403-7. PubMed ID: 7618106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300.
    Li QJ; Yang SH; Maeda Y; Sladek FM; Sharrocks AD; Martins-Green M
    EMBO J; 2003 Jan; 22(2):281-91. PubMed ID: 12514134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras/MAP kinase-dependent and -independent signaling pathways target distinct ternary complex factors.
    Hipskind RA; Büscher D; Nordheim A; Baccarini M
    Genes Dev; 1994 Aug; 8(15):1803-16. PubMed ID: 7958858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.